[stock-ticker]
Home » Archive by Category

Syndication

Laboratory Technician/Chemist (San Diego)

March 21, 2016 – 3:22 pm

H.M. Pitt Labs, an environmental laboratory, is seeking an individual who is hard working, reliable, and has a strong science background to assist in laboratory procedures. H.M. Pitt Labs is an equal opportunity employer who is dedicated in assisting […

Laboratory Technicians / Research Assistants (San Diego)

March 21, 2016 – 2:01 pm

Biotechnology company in Sorrento Valley seeking full time Laboratory Technicians and Research Assistants to perform a broad range of duties. We are expecting to grow tremendously for his year to come and are openly accepting and interviewing candida […

Job Openings (Santee)

March 21, 2016 – 1:59 pm

Scantibodies Laboratory, Inc., a 39 year old biotech company rooted in the heart of East San Diego County is currently looking for qualified candidates for a variety of available positions.
ENGINEERING TECHNICIAN – full time
FACILITIES TECHNICIAN- […

Process Development Chemist Needed to Complete Our Biotech Team! (Sorrento Valley)

March 21, 2016 – 1:36 pm

HIRING NOW!
This is a long term opportunity!
Shift: Mon-fri 7am-3:30pm
Pay: Competitive Pay DOE
Seeking an Oligo Process Development Chemist responsible for the development of new oligo processes, transfer to manufacturing and continuous improvem […

Plant/ Wildlife Biologist (San Diego)

March 21, 2016 – 1:25 pm

We provide environmental planning, regulatory permitting, technical studies that evaluate impacts to biological, cultural and marine resources, air quality and noise analyses, construction mitigation monitoring and GIS.
We have an immediate need for […

Sequenom Files Petition With the Supreme Court of the United States Requesting Review Of Decision On ‘540 Patent

March 21, 2016 – 1:05 pm

SAN DIEGO, March 21, 2016 /PRNewswire/ — Sequenom, Inc. (NASDAQ: SQNM), a life sciences company committed to enabling healthier lives through the development of innovative products and services, announced that it filed a petition today with the Supreme Court of the United States to review decisions by lower Federal courts that the claims of Sequenom’s U.S. Patent No. 6,258,540 (“‘540 Patent”) are not patent eligible under the patent eligibility criteria established by the Supreme Court’s Mayo Collaborative Services v. Prometheus Laboratories decision. In the petition, Sequenom urges the Court to hear the case because the Court is uniquely suited to reconcile and interpret the patent eligibility criteria established in its Mayo decision.  Those overly-expansive patent eligibility criteria have not only negatively impacted Sequenom’s patent, but have put into jeopardy the patentability of existing and future diagnostic method patent claims.

The judges at the U.S. Court of Appeals for the Federal Circuit felt “bound by the sweeping language of the test set out in Mayo” to hold the ‘540 patent invalid. The judges, and the twelve organizations that supported Sequenom at the Court of Appeals, recognized that an expansive application of the Mayo test for patent eligibility, such as in this case, will lead to untenable results—invalidating previously irreproachable inventions and precipitating what Court of Appeals Judge Lourie called “a crisis of patent law and medical innovation.” The Court of Appeals emphasized that the only clarifications that can avoid such results “must come from the Supreme Court.” 

“We continue to believe that the groundbreaking techniques embodied in the ‘540 patent are eligible for patent protection,” said Dirk van den Boom, Ph.D., President and CEO of Sequenom. “More broadly, we believe our case provides a compelling opportunity for the Supreme Court to clarify patent eligibility criteria to protect the significant investments made by Sequenom and other life science organizations that have undoubtedly advanced the standard of patient care and treatment, as well as encouraging future such investments.”

Sequenom believes that the existing lower court ruling will have little on-going business impact as the Company has been operating under the District Court’s invalidity ruling since October, 2013, as well as the pooling arrangement of NIPT intellectual property entered into with Illumina, Inc. in December, 2014. 

Separate and apart from any U.S. Supreme Court review of Sequenom’s ‘540 patent, the Company maintains valid and enforceable patents with claims equivalent to those of the ‘540 patent in Europe, Japan, Hong Kong, Canada and Australia.  Sequenom and Illumina are currently pursuing infringement actions in some of those jurisdictions. 

About Sequenom
Sequenom, Inc. (NASDAQ: SQNM) is a pioneering genetic testing company dedicated to women’s health through the development of innovative products and services.  The Company serves patients and physicians by providing early patient management information.  For more information, visit www.sequenom.com.

About Sequenom Laboratories
Sequenom Laboratories™, a CAP-accredited and CLIA-certified molecular diagnostics laboratory, has developed a broad range of laboratory tests, with a focus principally on prenatal care.  Branded under the names HerediT®, HerediT® UNIVERSAL, MaterniT® GENOME, MaterniT21® PLUS, NextView®, SensiGene® and VisibiliT™, these molecular genetic laboratory-developed tests provide early patient management information for obstetricians, geneticists, and maternal fetal medicine specialists. Sequenom Laboratories is changing the landscape in genetic diagnostics using proprietary cutting edge technologies. Visit www.laboratories.sequenom.com and follow @SequenomLabs.

SEQUENOM®, HerediT®, MaterniT®, NextView®, SensiGene®, VisibiliT and Sequenom Laboratories are trademarks of Sequenom, Inc. All other trademarks and service marks are the property of their respective owners.

Forward-Looking Statements 

Statements contained in this press release regarding matters that are not historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the development of innovative products and services and the expected impact of the Court’s decision.  Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements.  Risks are described more fully in the Company’s filings with the Securities and Exchange Commission, including without limitation the Company’s most recent Annual Report on Form 10-K and other documents subsequently filed with or furnished to the Securities and Exchange Commission.  All forward-looking statements contained in this press release speak only as of the date on which they were made.  The Company undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.

Logo – http://photos.prnewswire.com/prnh/20160225/337675LOGO

 

SOURCE Sequenom, Inc.

Blood Processing Technician (La Jolla)

March 21, 2016 – 12:45 pm

Job Summary
The technician in this position will be responsible for working within the clinical core team to handle/process human blood after collection by the phlebotomist. In addition to internally collected samples, external sites may also ship b […

Director/Principal Scientist/Scientist – Immunology – HD Biosciences, Inc. – San Diego, CA

March 21, 2016 – 12:12 pm

Preference will be given to candidates with prior pharmaceutical industry and/or biotechnology experience. HD Biosciences is a biology-focused preclinical drug…
From Indeed – 21 Mar 2016 19:12:49 GMT
– View all San Diego jobs

Director/Principal Scientist/Scientist – Immunology, Immunotherapy – HD Biosciences, Inc. – San Diego, CA

March 21, 2016 – 12:12 pm

Preference will be given to candidates with prior pharmaceutical industry and/or biotechnology experience. HD Biosciences is a biology-focused preclinical drug…
From Indeed – 21 Mar 2016 19:12:49 GMT
– View all San Diego jobs

Social Media Marketing Sales for Real Estate $40,000-$85,000 + Benefit (San Diego)

March 21, 2016 – 11:57 am

15-year-old Digital Marketing company seeking to hired new inside sales consultants. The company provides Social Media, Web Marketing, SEO and other online marketing solutions to businesses throughout the USA.
We especially are seeking to hire energe […